10:42 AM EDT, 03/21/2024 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on March 18, 2024, sold 17,219 shares in Corcept Therapeutics ( CORT ) for $430,475. Following the Form 4 filing with the SEC, Maduck has control over a total of 95,222 shares of the company, with 75,222 shares held directly and 20,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000095017024034264/xslF345X03/ownership.xml

Price: 24.65, Change: +0.24, Percent Change: +0.98